Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Onychomycosis (Tinea Unguium) Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral Type
      • 1.3.3 External Use Type
    • 1.4 Market Segment by Application
      • 1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Share by Application (2019-2025)
      • 1.4.2 Age under 18
      • 1.4.3 Age 18-50
      • 1.4.4 Age above 50
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size
      • 2.1.1 Global Onychomycosis (Tinea Unguium) Drug Revenue 2014-2025
      • 2.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales 2014-2025
    • 2.2 Onychomycosis (Tinea Unguium) Drug Growth Rate by Regions
      • 2.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Regions 2014-2019
      • 2.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers
      • 3.1.1 Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Onychomycosis (Tinea Unguium) Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Onychomycosis (Tinea Unguium) Drug Price by Manufacturers
    • 3.4 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Onychomycosis (Tinea Unguium) Drug Market
    • 3.6 Key Manufacturers Onychomycosis (Tinea Unguium) Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Type Sales and Revenue (2014-2019)
      • 4.1.2 External Use Type Sales and Revenue (2014-2019)
    • 4.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type
    • 4.3 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type
    • 4.4 Onychomycosis (Tinea Unguium) Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Onychomycosis (Tinea Unguium) Drug Sales by Application

    6 United States

    • 6.1 United States Onychomycosis (Tinea Unguium) Drug Breakdown Data by Company
    • 6.2 United States Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type
    • 6.3 United States Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Onychomycosis (Tinea Unguium) Drug Breakdown Data by Company
    • 7.2 European Union Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type
    • 7.3 European Union Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application

    8 China

    • 8.1 China Onychomycosis (Tinea Unguium) Drug Breakdown Data by Company
    • 8.2 China Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type
    • 8.3 China Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Onychomycosis (Tinea Unguium) Drug Breakdown Data by Company
    • 9.2 Rest of World Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type
    • 9.3 Rest of World Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application
    • 9.4 Rest of World Onychomycosis (Tinea Unguium) Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Onychomycosis (Tinea Unguium) Drug Sales by Countries
      • 9.4.2 Rest of World Onychomycosis (Tinea Unguium) Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Johnson & Johnson
      • 10.1.1 Johnson & Johnson Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.1.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.1.5 Johnson & Johnson Recent Development
    • 10.2 GSK
      • 10.2.1 GSK Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.2.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.2.5 GSK Recent Development
    • 10.3 Novartis
      • 10.3.1 Novartis Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.3.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.3.5 Novartis Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.4.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 Valeant Pharma
      • 10.5.1 Valeant Pharma Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.5.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.5.5 Valeant Pharma Recent Development
    • 10.6 Kaken Pharmaceutical
      • 10.6.1 Kaken Pharmaceutical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.6.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.6.5 Kaken Pharmaceutical Recent Development
    • 10.7 Galderma
      • 10.7.1 Galderma Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.7.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.7.5 Galderma Recent Development
    • 10.8 Xiuzheng Pharmaceutical
      • 10.8.1 Xiuzheng Pharmaceutical Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.8.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.8.5 Xiuzheng Pharmaceutical Recent Development
    • 10.9 Letai
      • 10.9.1 Letai Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.9.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.9.5 Letai Recent Development
    • 10.10 Qilu Pharmaceutical
      • 10.10.1 Qilu Pharmaceutical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Onychomycosis (Tinea Unguium) Drug
      • 10.10.4 Onychomycosis (Tinea Unguium) Drug Product Introduction
      • 10.10.5 Qilu Pharmaceutical Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Onychomycosis (Tinea Unguium) Drug Sales Channels
      • 11.2.2 Onychomycosis (Tinea Unguium) Drug Distributors
    • 11.3 Onychomycosis (Tinea Unguium) Drug Customers

    12 Market Forecast

    • 12.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type
    • 12.3 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application
    • 12.4 Onychomycosis (Tinea Unguium) Drug Forecast by Regions
      • 12.4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Onychomycosis (Tinea Unguium) Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Onychomycosis (Tinea Unguium) Drug.

      This report studies the global market size of Onychomycosis (Tinea Unguium) Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Onychomycosis (Tinea Unguium) Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Johnson & Johnson
      GSK
      Novartis
      Pfizer
      Valeant Pharma
      Kaken Pharmaceutical
      Galderma
      Xiuzheng Pharmaceutical
      Letai
      Qilu Pharmaceutical

      Market Segment by Product Type
      Oral Type
      External Use Type

      Market Segment by Application
      Age under 18
      Age 18-50
      Age above 50

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Onychomycosis (Tinea Unguium) Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Onychomycosis (Tinea Unguium) Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Onychomycosis (Tinea Unguium) Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now